#RENOVATEtrial

1/ Reading w interest the pre-print on IL-6 antagonists for COVID-19 fromREMAP-CAP.Especially bc of the methodsAn adaptive platform trial (bayesian) somewhat similar to what we are doing in the @RENOVATEtrial
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.